Ein langer Weg: metastasierendes Pankreaskarzinom/COVID-19-Infektion und protrahiertes Fatigue-Syndrom

Zusammenfassung

Der lange Behandlungsverlauf einer 78-jährigen Patientin mit einem schon bei Erstdiagnose diffus hepatisch metastasierten Pankreaskarzinom wird – mit besonderem Fokus auf unerwünschte Begleiterscheinungen von Therapie und Krankheit – in dieser Kasuistik vorgestellt. Die Patientin leidet schon seit Diagnosestellung an einem ausgeprägten Fatigue-Syndrom, das den privaten als auch den selbstständigen beruflichen Alltag belastet. Im Vordergrund der klinischen Symptomatik stehen körperliche Erschöpfung und kognitive Einschränkungen wie Konzentrationsstörungen. Neben der Schilderung des Krankheits- und Behandlungsverlaufs werden begleitende supportive Behandlungselemente beschrieben.

Abstract

The long course of treatment of a 78-year-old patient with a pancreatic carcinoma that was diffusely hepatic metastasized at the initial diagnosis is focused on the undesirable side effects of therapy and illness. The patient has suffered from a pronounced fatigue syndrome since the start of treatment that puts a strain on both private and self-employed professional everyday life. The main clinical symptoms are physical exhaustion and cognitive limitations such as poor concentration. In addition to describing the course of the disease and treatment, accompanying supportive treatment elements are described.

Schlüsselwörter

Pankreaskarzinom - Cancer Related Fatigue - Chemotherapie - Komplementärmedizin - supportive Therapie

Key words

Pancreatic carcinoma - cancer-related fatigue - chemotherapy - complementary medicine - supportive therapy

Publication History

Article published online:
01 April 2021

• Literatur

• 1 Bazzan AJ, Zabrecky G, Wintering N. et al. Retrospective evaluation of clinical experience with intravenous ascorbic acid in patients with cancer. Integr Cancer Ther 2018; 17: 912-920 DOI: 10.1177/1534735418775809.
• 2 Brami C, Bao T, Deng G. Natural products and complementary therapies for chemotherapy-induced peripheral neuropathy: A systematic review. Crit Rev Oncol Hematol 2016; 98: 325-334 DOI: 10.1016/j.critrevonc.2015.11.014.
• 3 Campbell MS, Carlini NA, Fleenor BS. Influence of curcumin on performance and post-exercise recovery. Crit Rev Food Sci Nutr 2020; 22: 1-11 DOI: 10.1080/10408398.2020.1754754.
• 4 Carfì A, Bernabei R, Landi F. Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent symptoms in patients after acute COVID-19. JAMA 2020; 324: 603-605 DOI: 10.1001/jama.2020.12603.
• 5 Cho IR, Kang H, Jo JH. et al. FOLFIRINOX vs gemcitabine/nab-paclitaxel for treatment of metastatic pancreatic cancer: Single-center cohort study. World J Gastrointest Oncol 2020; 12: 182-194 DOI: 10.4251/wjgo.v12.i2.182.
• 6 Dillon EL, Basra G, Horstman AM. et al. Cancer cachexia and anabolic interventions: a case report. J Cachexia Sarcopenia Muscle 2012; 3: 253-263 DOI: 10.1007/s13539-012-0066-6.
• 7 Gröber U, Kisters K, Adamietz IA. Vitamin D in der Onkologie: Update 2015. Med Monatsschr Pharm 2015; 38: 512-516
• 8 Gupta SC, Kim JH, Kannappan R. et al. Role of nuclear factor kappaB-mediated inflammatory pathways in cancer-related symptoms and their regulation by nutritional agents. Exp Biol Med (Maywood) 2011; 236: 658-671 DOI: 10.1258/ebm.2011.011028.
• 9 Inglis JE, Lin PJ, Kerns SL. et al. Nutritional interventions for treating cancer-related fatigue: A qualitative review. Nutr Cancer 2019; 71: 21-40 DOI: 10.1080/01635581.2018.1513046.
• 10 Ishaque S, Shamseer L, Bukutu C, Vohra S. Rhodiola rosea for physical and mental fatigue: a systematic review. BMC Complement Altern Med 2012; 12: 70 DOI: 10.1186/1472-6882-12-70.
• 11 Kornyakova VV, Badtieva VA, Balandin MY. Exploiting dietary supplements with antioxidant properties for enhancing physical efficiency at the state of physical fatigue in sports. Vopr Pitan 2020; 89: 86-96 DOI: 10.24411/0042-8833-2020-10032.
• 12 Kraft M, Kraft K, Lerch MM. L-Carnitin – mehr als nur eine supportive Therapie in der Behandlung des fortgeschrittenen Pankreaskarzinoms (CARPAN-Studie)?. Dtsch Z Onkol 2012; 44: 103-108 DOI: 10.1055/s-0032-1314696.
• 13 Leitlinienprogramm Onkologie. Leitlinie Pankreaskarzinom. https://www.leitlinienprogramm-onkologie.de/leitlinien/pankreaskarzinom/
• 14 Schöttker B, Kuznia S, Laetsch DC. et al. Protocol of the VICTORIA study: personalized vitamin D supplementation for reducing or preventing fatigue and enhancing quality of life of patients with colorectal tumor – randomized intervention trial. BMC Cancer 2020; 20: 739 DOI: 10.1186/s12885-020-07219-z.
• 15 Vieira ML, Fonseca FL, Costa LG. et al. Supplementation with selenium can influence nausea, fatigue, physical, renal, and liver function of children and adolescents with cancer. J Med Food 2015; 18: 109-117 DOI: 10.1089/jmf.2014.0030.
• 16 Wang-Gillam A, Hubner RA, Siveke JT. et al. NAPOLI-1 phase 3 study of liposomal irinotecan in metastatic pancreatic cancer: Final overall survival analysis and characteristics of long-term survivors. Eur J Cancer 2019; 108: 78-87 DOI: 10.1016/j.ejca.2018.12.007.